Laird Norton Wetherby Wealth Management’s Alexion Pharmaceuticals ALXN Stock Holding History

Laird Norton Wetherby Wealth Management’s Portfolio ALXN Stock Details ALXN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q3	–	Sell	-1,678	Closed	-$308K	–	972
2021 Q2	$308K	Sell	1,678 -2,152	-56%	-$369K	0.02%	710
2021 Q1	$585K	Buy	3,830 +16	+0.4%	+$2.48K	0.04%	397
2020 Q4	$596K	Buy	3,814 +2	+0.1%	+$257	0.04%	412
2020 Q3	$436K	Sell	3,812 -41	-1%	-$4.42K	0.04%	415
2020 Q2	$433K	Buy	3,853 +268	+7%	+$28.5K	0.04%	396
2020 Q1	$322K	Buy	3,585 +241	+7%	+$23.7K	0.04%	432
2019 Q4	$362K	Sell	3,344 -456	-12%	-$48.8K	0.04%	487
2019 Q3	$372K	Sell	3,800 -307	-7%	-$34.6K	0.04%	483
2019 Q2	$538K	Buy	4,107 +393	+11%	+$50.7K	0.06%	371
2019 Q1	$502K	Sell	3,714 -4,084	-52%	-$508K	0.06%	363
2018 Q4	$759K	Sell	7,798 -503	-6%	-$59.5K	0.11%	212
2018 Q3	$1.15M	Sell	8,301 -1,857	-18%	-$233K	0.14%	156
2018 Q2	$1.26M	Buy	10,158 +326	+3%	+$38.1K	0.17%	134
2018 Q1	$1.1M	Sell	9,832 -763	-7%	-$91.2K	0.15%	157
2017 Q4	$1.27M	Sell	10,595 -796	-7%	-$96.9K	0.18%	129
2017 Q3	$1.6M	Buy	11,391 +590	+5%	+$80.2K	0.24%	89
2017 Q2	$1.31M	Sell	10,801 -597	-5%	-$69.5K	0.22%	95
2017 Q1	$1.38M	Sell	11,398 -215	-2%	-$27.7K	0.25%	82
2016 Q4	$1.42M	Buy	11,613 +1,048	+10%	+$128K	0.28%	74
2016 Q3	$1.29M	Buy	10,565 +497	+5%	+$64K	0.26%	80
2016 Q2	$1.18M	Buy	10,068 +208	+2%	+$29.5K	0.26%	85
2016 Q1	$1.37M	Sell	9,860 -351	-3%	-$51.5K	0.32%	62
2015 Q4	$1.95M	Buy	10,211 +49	+0.5%	+$8.56K	0.47%	46
2015 Q3	$1.59M	Buy	10,162 +206	+2%	+$37.6K	0.41%	55
2015 Q2	$1.8M	Buy	9,956 +277	+3%	+$47.8K	0.43%	46
2015 Q1	$1.68M	Sell	9,679 -53	-0.5%	-$9.59K	0.41%	49
2014 Q4	$1.8M	Buy	9,732 +210	+2%	+$38.9K	0.45%	44
2014 Q3	$1.58M	Buy	9,522 +152	+2%	+$25K	0.44%	45
2014 Q2	$1.46M	Buy	9,370 +179	+2%	+$28.3K	0.41%	49
2014 Q1	$1.4M	Sell	9,191 -7,911	-46%	-$1.26M	0.4%	51
2013 Q4	$2.27M	Sell	17,102 -24,444	-59%	-$2.93M	0.65%	28
2013 Q3	$4.83M	Buy	+41,546	New	+$4.56M	1.51%	8

Other funds holding ALXN

BCI

Brinker Capital Investments Berwyn, Pennsylvania $11.7B AUM 21.33% 1-Year Est. Return

NICM

Neo Ivy Capital Management New York $379M AUM 28.34% 1-Year Est. Return

TAIM

TD Ameritrade Investment Management Omaha, Nebraska $9.4B AUM 7.2% 1-Year Est. Return

Barclays London, United Kingdom $416B AUM 33.63% 1-Year Est. Return

Retirement Group San Diego, California $279M AUM 22.21% 1-Year Est. Return

CFO

CVA Family Office Denver, Colorado $950M AUM 20.72% 1-Year Est. Return

MAM

Meeder Asset Management Dublin, Ohio $1.75B AUM 34.85% 1-Year Est. Return